Sukumar Nagendran
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sukumar Nagendran
Sukumar Nagendran is recorded as Board Member at Taysha Gene Therapies, Inc. (TSHA). Taysha Gene Therapies, Inc. reported in an 8-K filed December 22, 2022 that Sukumar Nagendran was appointed President and Head of Research and Development, effective December 16, 2022. The proxy statement of Taysha Gene Therapies, Inc. reports total compensation of $2,092,890 for Sukumar Nagendran in fiscal 2025, including a base salary of $608,166. Disclosed compensation is on record for 4 fiscal years. Sukumar Nagendran has spoken on 4 earnings calls and 1 other investor event across 1 company, most recently for Taysha Gene Therapies, Inc. on August 11, 2026.
“On December 16, 2022, the Board appointed Dr. Sukumar Nagendran as the Company's President and Head of Research and Development, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Taysha Gene Therapies, Inc. (TSHA)
Source not stated
Current -
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Taysha Gene Therapies, Inc.
Other people whose current roles at this company are on record from its filings.
- Sean Nolan CEO, Board Member
- Kamran Alam CFO
- Laura Sepp-Lorenzino Board Member
- Sean Stalfort Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Taysha Gene Therapies, Inc. (TSHA) | President and Head of Research and Development and Director | $608,166 | $2,092,890 |
| 2024 | Taysha Gene Therapies, Inc. (TSHA) | President and Head of Research and Development | $584,775 | $3,601,660 |
| 2023 | Taysha Gene Therapies, Inc. (TSHA) | President and Head of Research and Development | $565,000 | $1,248,120 |
| 2022 | Taysha Gene Therapies, Inc. (TSHA) | President and Head of Research and Development | $23,542 | $1,363,545 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.